Abstract
3582 Background: The early determination of drug response is a keystone in oncology, and CTC is a promising biomarker in mCRC. This study investigated the prognostic significance of a novel dual-en...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
